-transparent.png){kind=logo}
The effect of bumetanide in infants with congenital heart disease presenting with cardiac failure was studied. The study was divided into acute (3 days) and long-term (mean 10.5 weeks) cases. A total of 12 male infants was included in the acute study and 13 cases were evaluated in the long-term study. The dose used in the acute study (0.015 mg/kg) was suboptimal; notwithstanding it was found to cause significant natriuresis and chloruresis. Bumetanide in doses varying in different infants from as little as 0.015 mg/kg on alternate days to as much as 0.10 mg/kg daily was shown to be an effective diuretic for long-term use. No side effects were observed in either study.
Related Publications
O C Ward, and
L K Lam
January 1976,
Current medical research and opinion,
O C Ward, and
L K Lam
August 1984,
Kidney international,
O C Ward, and
L K Lam
January 1975,
Postgraduate medical journal,
O C Ward, and
L K Lam
January 1981,
Journal of clinical pharmacology,
O C Ward, and
L K Lam
July 1980,
Il Farmaco; edizione pratica,
O C Ward, and
L K Lam
January 1981,
Giornale italiano di cardiologia,
O C Ward, and
L K Lam
March 1954,
Transactions. American College of Cardiology,
O C Ward, and
L K Lam
August 1971,
Archives of disease in childhood,
O C Ward, and
L K Lam
January 1976,
Paediatrica Indonesiana,
